MQSA governs your accreditation, equipment, recordkeeping, and reporting, and the FDA final rule effective September 10, 2024 now requires standardized breast density notification in every mammography report and patient summary. We make sure your reporting software and templates deliver that language consistently and that your records are retained and retrievable for FDA and accrediting-body inspections. Systems like Magview, MRS, and PenRad handle much of the structured BI-RADS and density reporting, and we keep those interfaces healthy so nothing drops between the modality, PACS, and report. We also maintain the audit trails, backups, and access controls that HIPAA requires. Compliance is easier when your IT is built to support it.